Evidence map›Paper›PMID 40133922›Full record

ArticleBMC health services research2025

A community-focused cervical and breast cancer screening program using a sustainable funding model in a training center in Ghana.

Kofi Effah, Ethel Tekpor, Comfort Mawusi Wormenor, Gifty Enyonam Abiti, Theodore Wordui, David Akanvarewon Dan-Braimah, Pikus Enu-Kwasi, Gifty Belinda Klutsey, Edna Sesenu, Elagbe Goka and 4 more

Abstract read
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kofi EffahCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Ethel TekporCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Comfort Mawusi WormenorCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Gifty Enyonam AbitiCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Theodore WorduiCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
David Akanvarewon Dan-BraimahCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Pikus Enu-KwasiCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Gifty Belinda KlutseyCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Edna SesenuCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Elagbe GokaNorth Tongu District Health Directorate, Battor, Volta Region, Ghana.
George Griffith LegbedzeNorth Tongu District Health Directorate, Battor, Volta Region, Ghana.
Seyram KemaworCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Stephen DanyoCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana.
Nana Owusu Mensah EsselCatholic Hospital, P. O. Box 2, via Sogakope, Battor, Volta Region, Ghana. nanaowus@ualberta.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile Ghana prepares to roll out a nationwide breast and cervical (pre)cancer screening policy, it is necessary to continuously document high-impact and scalable models. Over the years, the Cervical Cancer Prevention and Training Centre (CCPTC), Battor, has utilized a sustainable funding model in which each trainee pays for 15 women to be screened with visual inspection with acetic acid. This paper details the framework of community-focused trainer-led coordinated cervical and breast screening outreaches carried out under this model. The paper further reports the outcomes of screening over a 5-year period and discusses the advantages and shortcomings of the model in an effort to make recommendations for the development and scale-up of combined cervical and breast screening in a largely opportunistic setting.

methodsThis descriptive retrospective cross-sectional study investigated women who underwent cervical precancer screening using visual inspection with acetic acid or mobile colposcopy and/or high-risk human papillomavirus (hr-HPV) DNA testing between September 2017 and July 2022 (n = 2,273) and clinical breast examination between June 2021 and March 2023 (n = 622) by trainees of the CCPTC on outreaches conducted primarily to solidify their practical skills. For women screened using HPV DNA testing and visual inspection, respectively, the study explored factors associated with HPV infection or visual inspection 'positivity' using nominal logistic regression.

resultsThe overall prevalence of hr-HPV infection was 14.3% (95% CI, 10.0-19.6) among women with valid results for hr-HPV DNA testing, while the overall visual inspection 'positivity' rate was 2.8% (95% CI, 2.2-3.6). After controlling for age, earning an income was the only factor associated with hr-HPV infection (aOR = 3.00; 95% CI, 1.35 - 6.64; p-value = 0.007). Factors associated with visual inspection 'positivity' after adjusting for age were: number of births (aOR = 0.71; 95% CI, 0.52 - 0.97; p-value = 0.029), number of lifetime pregnancies (aOR = 0.79; 95% CI, 0.67 - 0.93; p-value = 0.004), being single (aOR = 2.42; 95% CI, 1.19 - 4.90; p-value = 0.014), and earning an income (aOR = 0.44; 95% CI, 0.26 - 0.74; p-value = 0.002). Breast examination showed clinically significant masses in 20 women (3.2%), lymphadenopathy in 13 (2.1%), and nipple discharge in 37 women (6.0%) and only n = 3/67 women (4.5%) requiring referral followed up for further management.

conclusionWhile the outreach approach adopted by the CCPTC has myriad benefits, further evidence-based studies and structured program evaluations are needed to assess if this approach can be adopted on a large scale, especially without the backing of a training institution with the needed resources and capacity to investigate and manage screen positives.

Indexed as

Breast NeoplasmsEarly Detection of CancerMass ScreeningUterine Cervical NeoplasmsAdultCross-Sectional StudiesFemaleGhanaHumansMiddle AgedRetrospective StudiesBreast cancerCancer screeningCervical precancerClinical breast examinationHuman papillomavirus infectionsWomen’s health

Identifiers

PMID40133922
PMCPMC11934490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.